|
1
|
Goekoop-Ruiterman YP and Huizinga TW:
Rheumatoid arthritis: Can we achieve true drug-free remission in
patients with RA? Nat Rev Rheumatol. 6:68–70. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McInnes IB and Schett G: The pathogenesis
of rheumatoid arthritis. N Engl J Med. 365:2205–2219. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gravallese EM, Manning C, Tsay A, Naito A,
Pan C, Amento E and Goldring SR: Synovial tissue in rheumatoid
arthritis is a source of osteoclast differentiation factor.
Arthritis Rheum. 43:250–258. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shigeyama Y, Pap T, Kunzler P, Simmen BR,
Gay RE and Gay S: Expression of osteoclast differentiation factor
in rheumatoid arthritis. Arthritis Rheum. 43:2523–2530. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gracie JA, Forsey RJ, Chan WL, Gilmour A,
Leung BP, Greer MR, Kennedy K, Carter R, Wei XQ, Xu D, et al: A
proinflammatory role for IL-18 in rheumatoid arthritis. J Clin
Invest. 104:1393–1401. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rech J, Hueber AJ, Finzel S, Englbrecht M,
Haschka J, Manger B, Kleyer A, Reiser M, Cobra JF, Figueiredo C, et
al: Prediction of disease relapses by multibiomarker disease
activity and autoantibody status in patients with rheumatoid
arthritis on tapering DMARD treatment. Ann Rheum Dis. 75:1637–1644.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Agrawal S, Misra R and Aggarwal A:
Autoantibodies in rheumatoid arthritis: Association with severity
of disease in established RA. Clin Rheumatol. 26:201–204. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
He J, Tsai LM, Leong YA, Hu X, Ma CS,
Chevalier N, Sun X, Vandenberg K, Rockman S, Ding Y, et al:
Circulating precursor CCR7(lo)PD-1(hi) CXCR5+ CD4+ T cells indicate
Tfh cell activity and promote antibody responses upon antigen
reexposure. Immunity. 39:770–781. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bennett JC: The role of T lymphocytes in
rheumatoid arthritis and other autoimmune diseases. Arthritis
Rheum. 58 Suppl 2:S53–S57. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Holmdahl R, Klareskog L, Rubin K, Björk J,
Smedegård G, Jonsson R and Andersson M: Role of T lymphocytes in
murine collagen induced arthritis. Agents Actions. 19:295–305.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Godefroy E, Zhong H, Pham P, Friedman D
and Yazdanbakhsh K: TIGIT-positive circulating follicular helper T
cells display robust B-cell help functions: Potential role in
sickle cell alloimmunization. Haematologica. 100:1415–1425. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ma J, Zhu C, Ma B, Tian J, Baidoo SE, Mao
C, Wu W, Chen J, Tong J, Yang M, et al: Increased frequency of
circulating follicular helper T cells in patients with rheumatoid
arthritis. Clin Dev Immunol. 2012:8274802012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang J, Shan Y, Jiang Z, Feng J, Li C, Ma
L and Jiang Y: High frequencies of activated B cells and T
follicular helper cells are correlated with disease activity in
patients with new-onset rheumatoid arthritis. Clin Exp Immunol.
174:212–220. 2013.PubMed/NCBI
|
|
14
|
Raptopoulou AP, Bertsias G, Makrygiannakis
D, Verginis P, Kritikos I, Tzardi M, Klareskog L, Catrina AI,
Sidiropoulos P and Boumpas DT: The programmed death 1/programmed
death ligand 1 inhibitory pathway is up-regulated in rheumatoid
synovium and regulates peripheral T cell responses in human and
murine arthritis. Arthritis Rheum. 62:1870–1880. 2010.PubMed/NCBI
|
|
15
|
Moret FM, van der Wurff-Jacobs KM, Bijlsma
JW, Lafeber FP and van Roon JA: Synovial T cell hyporesponsiveness
to myeloid dendritic cells is reversed by preventing PD-1/PD-L1
interactions. Arthritis Res Ther. 16:4972014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li S, Peng D, He Y, Zhang H, Sun H, Shan
S, Song Y, Zhang S, Xiao H, Song H and Zhang M: Expression of TIM-3
on CD4+ and CD8+ T cells in the peripheral blood and synovial fluid
of rheumatoid arthritis. APMIS. 122:899–904. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang F, Hou H, Wu S, Tang Q, Liu W, Huang
M, Yin B, Huang J, Mao L, Lu Y and Sun Z: TIGIT expression levels
on human NK cells correlate with functional heterogeneity among
healthy individuals. Eur J Immunol. 45:2886–2897. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Flores-Borja F, Jury EC, Mauri C and
Ehrenstein MR: Defects in CTLA-4 are associated with abnormal
regulatory T cell function in rheumatoid arthritis. Proc Natl Acad
Sci USA. 105:pp. 19396–19401. 2008; View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Latchman Y, Wood CR, Chernova T, Chaudhary
D, Borde M, Chernova I, Iwai Y, Long AJ, Brown JA, Nunes R, et al:
PD-L2 is a second ligand for PD-1 and inhibits T cell activation.
Nat Immunol. 2:261–268. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nishimura H, Okazaki T, Tanaka Y, Nakatani
K, Hara M, Matsumori A, Sasayama S, Mizoguchi A, Hiai H, Minato N
and Honjo T: Autoimmune dilated cardiomyopathy in PD-1
receptor-deficient mice. Science. 291:319–322. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dai S, Jia R, Zhang X, Fang Q and Huang L:
The PD-1/PD-Ls pathway and autoimmune diseases. Cell Immunol.
290:72–79. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wan B, Nie H, Liu A, Feng G, He D, Xu R,
Zhang Q, Dong C and Zhang JZ: Aberrant regulation of synovial T
cell activation by soluble costimulatory molecules in rheumatoid
arthritis. J Immunol. 177:8844–8850. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hatachi S, Iwai Y, Kawano S, Morinobu S,
Kobayashi M, Koshiba M, Saura R, Kurosaka M, Honjo T and Kumagai S:
CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid
arthritis synovial fluid. J Rheumatol. 30:1410–1419.
2003.PubMed/NCBI
|
|
24
|
Li S, Liao W, Chen M, Shan S, Song Y,
Zhang S, Song H and Yuan Z: Expression of programmed death-1 (PD-1)
on CD4+ and CD8+ T cells in rheumatoid arthritis. Inflammation.
37:116–121. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Arnett FC, Edworthy SM, Bloch DA, McShane
DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS,
et al: The American rheumatism assocaition 1987 revised criteria
for the classification of rheumatoid arthritis. Arthr Rhuem.
31:315–324. 1988. View Article : Google Scholar
|
|
26
|
Prevoo ML, van't Hof MA, Kuper HH, van
Leeuwen MA, van de Putte LB and van Riel PL: Modified disease
activity scores that include twenty-eight-joint counts. Development
and validation in a prospective longitudinal study of patients with
rheumatoid arthritis. Arthritis Rheum. 38:44–48. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lajas C, Abasolo L, Bellajdel B,
Hernández-García C, Carmona L, Vargas E, Lázaro P and Jover JA:
Costs and predictors of costs in rheumatoid arthritis: A
prevalence-based study. Arthritis Rheum. 49:64–70. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yuan FL, Li X, Lu WG, Li CW, Xu RS and
Dong J: IL-33: A promising therapeutic target for rheumatoid
arthritis? Expert Opin Ther Targets. 15:529–534. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wright HL, Moots RJ and Edwards SW: The
multifactorial role of neutrophils in rheumatoid arthritis. Nat Rev
Rheumatol. 10:593–601. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cohen S and Emery P: The American College
of Rheumatology/European League Against Rheumatism Criteria for the
classification of rheumatoid arthritis: A game changer. Ann Rheum
Dis. 69:1575–1576. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Carruthers DM, Arrol HP, Bacon PA and
Young SP: Dysregulated intracellular Ca2+ stores and
Ca2+ signaling in synovial fluid T lymphocytes from
patients with chronic inflammatory arthritis. Arthritis Rheum.
43:1257–1265. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Malemud CJ: Dysfunctional immune-mediated
inflammation in rheumatoid arthritis dictates that development of
anti-rheumatic disease drugs target multiple intracellular
signaling pathways. Antiinflamm Antiallergy Agents Med Chem.
10:78–84. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Good-Jacobson KL, Szumilas CG, Chen L,
Sharpe AH, Tomayko MM and Shlomchik MJ: PD-1 regulates germinal
center B cell survival and the formation and affinity of long-lived
plasma cells. Nat Immunol. 11:535–542. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu R, Wu Q, Su D, Che N, Chen H, Geng L,
Chen J, Chen W, Li X and Sun L: A regulatory effect of IL-21 on T
follicular helper-like cell and B cell in rheumatoid arthritis.
Arthritis Res Ther. 14:R2552012. View
Article : Google Scholar : PubMed/NCBI
|
